Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Apomorphine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Apolipoproteins E (genetics) < Apomorphine < Apomorphine (administration & dosage)  Facettes :

List of bibliographic references indexed by Apomorphine

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
004B41 (2000) Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Apomorphine: An underutilized therapy for Parkinson's disease
004C58 (1999) Anette Schrag [Royaume-Uni] ; Ludwig Schelosky [Allemagne] ; Udo Scholz [Allemagne] ; Werner Poewe [Autriche]Reduction of parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single‐dose challenges
004D38 (1999) Marcelo Merello [Argentine] ; Andrew Lees (neurologue) [Royaume-Uni] ; Jorge Balej [Argentine] ; Angel Cammarota [Argentine] ; Ram N Leiguarda [Argentine]GPi Firing rate modification during beginning‐of‐dose motor deterioration following acute administration of apomorphine
004E08 (1999) Edna Grünblatt [Israël] ; Silvia Mandel [Israël] ; Tamara Berkuzki [Israël] ; M. B. H. Youdim [Israël]Apomorphine protects against MPTP‐induced neurotoxicity in mice
004E09 (1999) Marcelo Merello [Argentine] ; Jorge Balej [Argentine] ; Marina Delfino [Argentine] ; Angel Cammarota [Argentine] ; Osvaldo Betti [Argentine] ; Ram N Leiguarda [Argentine]Apomorphine induces changes in GPi spontaneous outflow in patients with parkinson's disease
004E10 (1999) Elena Moro [Italie] ; Alberto Albanese [Italie, Suisse]Apomorphine and levodopa challenge in patients with a focal midbrain lesion
004E25 (1999) William Ondo [États-Unis] ; Christine Hunter [États-Unis] ; Michael Almaguer [États-Unis] ; Joseph Jankovic [États-Unis]A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease
004E85 (1998) van Laar ; Bob Van Hilten ; Cees Neef ; A. Wijnand F. Rutgers ; Stan Pavel ; J. Anthony BruijnThe role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: A histologic study
005042 (1998) Marcelo Merello [Argentine] ; Angel Cammarota [Argentine] ; Maria I. Nouzeilles [Argentine] ; Osvaldo Betti [Argentine] ; Ram N Leiguarda [Argentine]Confirmation of the antidyskinetic effect of posteroventral pallidotomy by means of an intraoperative apomorphine test
005069 (1998) John D. O'Sullivan [Australie] ; Andrew J. Hughes [Australie]Apomorphine‐induced penile erections in Parkinson's disease
005070 (1998) Michael Gassen [Allemagne] ; Aviva Gross [Israël] ; Moussa B. H. Youdim [Israël]Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6‐Hydroxydopamine
005094 (1998) Richard B. Dewey Jr [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Joseph Y. Matsumoto [États-Unis]A double‐blind, placebo‐controlled study of intranasal apomorphine spray as a rescue agent for off‐states in Parkinson's disease
005099 (1998) Schwarz [Allemagne] ; Klaus Tatsch [Allemagne] ; Thomas Gasser [Allemagne] ; Guy Arnold [Allemagne] ; Oliver Pogarell [Allemagne] ; Gais Künig [Allemagne] ; Wolfgang H. Oertel [Allemagne]123I‐IBZM binding compared with long‐term clinical follow up in patients with de novo parkinsonism
005659 (1996) Tison [France] ; L. Wiart [France] ; M. Guatterie [France] ; N. Fouillet [France] ; V. Lozano [France] ; P. Henry [France] ; M. Barat [France]Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease
005673 (1996) Eichhorn [Allemagne] ; T. Gasser [Allemagne] ; N. Mai [Allemagne] ; C. Marquardt [Allemagne] ; G. Arnold [Allemagne] ; J. Schwarz [Allemagne] ; W. H. Oertel [Allemagne]Computational analysis of open loop handwriting movements in Parkinson's disease: A rapid method to detect dopamimetic effects
005721 (1996) van Laar [Pays-Bas] ; C. Neef [Pays-Bas] ; M. Danhof [Pays-Bas] ; K. I. Roon [Pays-Bas] ; R. A. C. Roos [Pays-Bas]A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease
005848 (1995) Przedborski [Belgique, États-Unis] ; Marc Levivier [Belgique, États-Unis] ; Christian Raftopoulos [Belgique] ; Ali B. Naini [États-Unis] ; Jerzy Hildebrand [Belgique]Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans
005942 (1995) Gancher [États-Unis] ; John G. Nutt [États-Unis] ; William R. Woodward [États-Unis]Apomorphine infusional therapy in parkinson's disease: Clinical utility and lack of tolerance
005D26 (1993) A. J. Hughes [Royaume-Uni] ; Susan Bishop [Royaume-Uni] ; Birgit Kleedorfer [Royaume-Uni] ; Nora Turjanski [Royaume-Uni] ; W. Fernandez [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. Stern [Royaume-Uni]Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years
005E19 (1993) Bonuccelli [Italie] ; P. Piccini [Italie] ; P. Del Dotto [Italie] ; G. Rossi [Italie] ; G. U. Corsini [Italie] ; A. Muratorio [Italie]Apomorphine test for dopaminergic responsiveness: A dose assessment study
005F93 (1992) Schwarz [Allemagne] ; K. Tatsch [Allemagne] ; T. Vogl [Allemagne] ; C. M. Kirsch [Allemagne] ; C. Trenkwalder [Allemagne] ; G. Arnold [Allemagne] ; T. Gasser [Allemagne] ; W. H. Oertel [Allemagne]Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM‐SPECT in a Wilson's disease patient with generalized dystonia

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Apomorphine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Apomorphine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Apomorphine
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024